Letter to the Editor: Long-term experience in treating autoimmune hepatitis with acute presentation

Affiliations

Comment

Keiichi Fujiwara et al. Liver Transpl. 2023.

. 2023 Sep 1;29(9):E31-E32.

doi: 10.1097/LVT.0000000000000164. Epub 2023 Apr 24.

¹ Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.

No abstract available

Comment on

Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America.
Enke T, Livingston S, Rule J, Stravitz T, Rakela J, Bass N, Reuben A, Tujios S, Larson A, Sussman N, Durkalski V, Lee W, Ganger D. Enke T, et al. Liver Transpl. 2023 Jun 1;29(6):570-580. doi: 10.1097/LVT.0000000000000105. Epub 2023 Feb 27. Liver Transpl. 2023. PMID: 36825579 Free PMC article.

1. Enke T, Livingston S, Rule J, Stravitz T, Rakela J, Bass N, et al. Autoimmune hepatitis presenting as acute liver failure. A 20-year retrospective review of North America. Liver Transpl. 2023;29:570–80.
1. Fujiwara K, Yasui S, Kondo T, Nakamura M, Arai M, Kanda T, et al. Thirty‐two years’ experience of treating fulminant hepatitis in a Japanese single center. Hepatol Res. 2022;53:357–369.
1. Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, et al. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure. J Hepatobiliary Pancreat Sci. 2016;23:212–219.
1. Fujiwara K, Nakayama N, Kato N, Yokosuka O, Tsubouchi H, Takikawa H, et al. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: A subanalysis based on nationwide surveys between 2010 and 2015. J Gastroenterol. 2020; 55: 888–898.
1. Fujiwara K, Yokosuka O, Kato N. Histological re-evaluation of autoimmune hepatitis with acute presentation. Liver Int. 2022;42:1916–1917.